Abstract:Background: MicroRNA-22 (miR-22) has recently been reported to play a regulatory role during vascular smooth muscle cell (VSMC) differentiation from stem cells, but little is known about its target genes and related pathways in mature VSMC phenotypic modulation or its clinical implication in neointima formation following vascular injury. Methods: We applied a wire-injury mouse model, and local delivery of AgomiR-22 or miR-22 inhibitor, as well, to explore the therapeutic potential of miR-22 in vascular diseases. Furthermore, normal and diseased human femoral arteries were harvested, and various in vivo, ex vivo, and in vitro models of VSMC phenotype switching were conducted to examine miR-22 expression during VSMC phenotype switching. Results: Expression of miR-22 was closely regulated during VSMC phenotypic modulation. miR-22 overexpression significantly increased expression of VSMC marker genes and inhibited VSMC proliferation and migration, whereas the opposite effect was observed when endogenous miR-22 was knocked down. As expected, 2 previously reported miR-22 target genes, MECP2 (methyl-CpG binding protein 2) and histone deacetylase 4, exhibited a regulatory role in VSMC phenotypic modulation. A transcriptional regulator and oncoprotein, EVI1 (ecotropic virus integration site 1 protein homolog), has been identified as a novel miR-22 target gene in VSMC phenotypic modulation. It is noteworthy that overexpression of miR-22 in the injured vessels significantly reduced the expression of its target genes, decreased VSMC proliferation, and inhibited neointima formation in wire-injured femoral arteries, whereas the opposite effect was observed with local application of a miR-22 inhibitor to injured arteries. We next examined the clinical relevance of miR-22 expression and its target genes in human femoral arteries. We found that miR-22 expression was significantly reduced, whereas MECP2 and EVI1 expression levels were dramatically increased, in diseased in comparison with healthy femoral human arteries. This inverse relationship between miR-22 and MECP2 and EVI1 was evident in both healthy and diseased human femoral arteries. Conclusions: Our data demonstrate that miR-22 and EVI1 are novel regulators of VSMC function, specifically during neointima hyperplasia, offering a novel therapeutic opportunity for treating vascular diseases.

Augmentation of miR-202 in varicose veins modulates phenotypic transition of vascular smooth muscle cells by targeting proliferator-activated receptor-γ coactivator-1α.

MicroRNA-125a-mediated Regulation of the Mevalonate Signaling Pathway Contributes to High Glucose-Induced Proliferation and Migration of Vascular Smooth Muscle Cells

miR‐200a‐3p inhibits the PDGF‐BB‐induced proliferation of VSMCs by affecting their phenotype‐associated proteins

Mir-22 is a Novel Mediator of Vascular Smooth Muscle Cell Phenotypic Modulation and Neointima Formation

miR-16-5p Is a Novel Mediator of Venous Smooth Muscle Phenotypic Switching

Mir-92A Inhibits Vascular Smooth Muscle Cell Apoptosis: Role of the MKK4–JNK Pathway

MicroRNA-92 regulates vascular smooth muscle cell function by targeting KLF4 during vascular restenosis and injury

microRNA-18a-5p promotes vascular smooth muscle cell phenotypic switch by targeting Notch2 as therapeutic targets in vein grafts restenosis

Role of Mir-199B-5p in Regulating Angiogenesis in Mouse Myocardial Microvascular Endothelial Cells Through HSF1/VEGF Pathway.

MiR‐205 promotes endothelial progenitor cell angiogenesis and deep vein thrombosis recanalization and resolution by targeting PTEN to regulate Akt/autophagy pathway and MMP2 expression

The PGC-1α/NRF1/miR-378a Axis Protects Vascular Smooth Muscle Cells from FFA-induced Proliferation, Migration and Inflammation in Atherosclerosis.

MiR-340 Promotes the Proliferation of Vascular Smooth Muscle Cells by Targeting von Hippel–Lindau Tumor Suppressor Gene

The Etiology and Molecular Mechanism Underlying Smooth Muscle Phenotype Switching in Intimal Hyperplasia of Vein Graft and the Regulatory Role of microRNAs

Functional screening identifies novel miRNAs inhibiting Vascular Smooth Muscle Cell proliferation

MicroRNA-92a -mediated endothelial to mesenchymal transition controls vein graft neointimal lesion formation

MicroRNA-31 Controls Phenotypic Modulation of Human Vascular Smooth Muscle Cells by Regulating Its Target Gene Cellular Repressor of E1A-stimulated Genes

Microrna-199b Modulates Vascular Cell Fate During Ips Cell Differentiation by Targeting the Notch Ligand Jagged1 and Enhancing Vegf Signaling

Murine Cytomegalovirus Infection Induced miR-1929-3p Down-Regulation Promotes the Proliferation and Apoptosis of Vascular Smooth Muscle Cells in Mice by Targeting Endothelin A Receptor and Downstream NLRP3 Activation Pathway

Upregulation of Mir-483-3p Contributes to Endothelial Progenitor Cells Dysfunction in Deep Vein Thrombosis Patients Via SRF.

Mir-21 Induces Endothelial Progenitor Cells Proliferation and Angiogenesis Via Targeting FASLG and is a Potential Prognostic Marker in Deep Venous Thrombosis

miR-10b-5p regulates venous endothelial cells in deep venous thrombosis by targeting MFG-E8